Navigation Links
Drug-resistant MRSA bacteria -- here to stay in both hospital and community
Date:3/15/2013

The drug-resistant bacteria known as MRSA, once confined to hospitals but now widespread in communities, will likely continue to exist in both settings as separate strains, according to a new study.

The prediction that both strains will coexist is reassuring because previous projections indicated that the more invasive and fast-growing community strains would overtake and eliminate hospital strains, possibly posing a threat to public health.

Researchers at Princeton University used mathematical models to explore what will happen to community and hospital MRSA strains, which differ genetically. Originally MRSA, which is short for methicillin-resistant Staphylococcus aureus, was confined to hospitals. However, community-associated strains emerged in the past decade and can spread widely from person to person in schools, athletic facilities and homes.

Both community and hospital strains cause diseases ranging from skin and soft-tissue infections to pneumonia and septicemia. Hospital MRSA is resistant to numerous antibiotics and is very difficult to treat, while community MRSA is resistant to fewer antibiotics.

The new study found that these differences in antibiotic resistance, combined with more aggressive antibiotic usage patterns in hospitals versus the community setting, over time will permit hospital strains to survive despite the competition from community strains. Hospital-based antibiotic usage is likely to successfully treat patients infected with community strains, preventing the newcomer strains from spreading to new patients and gaining the foothold they need to out-compete the hospital strains.

The researchers made their predictions by using mathematical models of MRSA transmission that take into account data on drug-usage, resistance profiles, person-to-person contact, and patient age.


'/>"/>

Contact: Catherine Zandonella
czandone@princeton.edu
Princeton University
Source:Eurekalert

1

GOOD

Page: 1

Related biology news :

1. IBNs Droplet Array sheds light on drug-resistant cancer stem cells
2. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
3. Sanctuary chimps show high rates of drug-resistant staph
4. Univ. of MD School of Medicine to study drug-resistant malaria in Myanmar
5. New compound overcomes drug-resistant Staph infection in mice
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. Leading evolutionary scientist to discuss how genome of bacteria has evolved
8. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
9. Team discovers how bacteria resist a Trojan horse antibiotic
10. From scourge to saint: E. coli bacteria becomes a factory - to make cheaper, faster pharmaceuticals
11. Bacterial shock to recapture essential phosphate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... MD, June 18, 2013: The Association for Molecular Pathology ... of American Societies for Experimental Biology (FASEB) on July ... membership on June 3, 2013. , The 26 ... and share a common vision for the advancement of ... biomedical and translational research is more important now than ...
(Date:6/18/2013)... a chemical modification of DNA and this modification ... DNA sequence. Until now, scientists believed that this ... genes. Today, a team of researchers from the ... Dermitzakis, Louis-Jeantet Professor at the Faculty of Medicine, ... and that DNA methylation may play both a ...
(Date:6/17/2013)... MA Women in the U.S. exposed to high levels ... likely to have a child with autism as women who ... study from Harvard School of Public Health (HSPH). It is ... and air pollution across the U.S. , "Our findings raise ... the women in our study lived in areas where risk ...
Breaking Biology News(10 mins):The secret of DNA methylation 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... team led by Johns Hopkins scientists has,found the ... human immune,system's remarkable ability to recognize and respond ... a family of genes whose,only apparent function is ... ,essentially cut themselves out of the genetic material, ...
... to investigate the safety of a vaccine against H5N1 ... Diseases (NIAID), part of the National Institutes of Health ... and Los Angeles will enroll a total of 450 ... NIAID-sponsored Vaccine and Treatment Evaluation Units (VTEU). , “While ...
... Roger Brent, President and Director of Research at ... announced today ,the release of a new approach ... 2005 edition of Nature,Biotechnology.,The research article, entitled ... 1.0" (pdf) ,describes MSI's discrete stochastic event simulator, ...
Cached Biology News:Gene sequencing explains bioremediation 'bug' 2Gene sequencing explains bioremediation 'bug' 3NIAID Initiates Trial of Experimental Avian Flu Vaccine 2MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 2MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 3
(Date:6/19/2013)... (PRWEB) June 19, 2013 Bayer CropScience ... first Bayer Bee Care Community Leadership Award. The award ... Congressional Reception in Washington, D.C., an event where ... to the world’s food supply. , The Bayer ... harnessed the power of the honey bee colony to ...
(Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... up with financial software provider BlackLine Systems  and ... SAP ) for a webinar next week entitled ... Solutions from BlackLine and SAP to Help Keep Its Account ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at ...
(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...
(Date:6/19/2013)... Austin, TX (PRWEB) June 19, 2013 ... new application report that details the measurement of sulfur ... NEX QC+ high resolution benchtop EDXRF analyzer . ... with standard test method ISO 13032. This International ... method for the determination of sulfur content in automotive ...
Breaking Biology Technology:Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
... SEATTLE, Aug. 18, 2011 Cell Therapeutics, Inc. ("CTI") ... that enrollment has opened for a randomized phase II ... PPX) and radiation ("RT") to the combination of temozolomide ... a high-grade malignant brain tumor. The objectives ...
... Biologics, LLC has announced a collaboration with Dr. ... supervise all small non consumable animal veterinary related activities ... NADA approvals for Panavira™ including (but not limited to) ... feline leukemia (FeLv) and feline immune deficiency (FIU). ...
... 17, 2011 SynCardia Systems, Inc. ( www.syncardia.com ), ... , announced today that University of Muenster in Germany ... the Total Artificial Heart after 89 days of support. ... Jan. 14, 60-year-old Jan Detert was admitted to University ...
Cached Biology Technology:Randomized Study Comparing Cell Therapeutics' OPAXIO (Paclitaxel Poliglumex) and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment 2Randomized Study Comparing Cell Therapeutics' OPAXIO (Paclitaxel Poliglumex) and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment 3Randomized Study Comparing Cell Therapeutics' OPAXIO (Paclitaxel Poliglumex) and Radiotherapy to Standard of Care Temozolomide and Radiotherapy Treatment Open for Enrollment 4Dr. Lester Mandelker to Collaborate with Nuovo Biologics, LLC 2University of Muenster Bridges 1st Patient to Transplant with SynCardia's Total Artificial Heart 2
... Immunogen: Peptide corresponding ... human, mouse, and rat phospho-FAK (Ser843) ... NM_153831 Quality ... Molecular Weight: ...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
Biology Products: